0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Intelligent Design: How AI-Powered Drug Discovery Is Revolutionizing Pharmaceutical DevelopmentThe AI-Driven Drug Discovery Market is experiencing explosive growth as AI-powered drug discovery continues to revolutionize pharmaceutical development and therapeutic innovation. According to market reports, the global AI-Driven Drug Discovery Market was valued at USD 2.48 billion in 2024 and is projected to reach USD 40.0 billion by 2035, exhibiting an extraordinary CAGR of 28.8%...0 Комментарии 0 Поделились 956 Просмотры 0 предпросмотр
-
Pediatric Drug Research and Development Platform Market: Pharmaceutical Companies Lead as CROs Drive EfficiencyThe [Pediatric Drug Research and Development Platform Market] is powered by a diverse group of end-users, with pharmaceutical companies currently representing the largest segment. Their extensive R&D budgets and pipelines, particularly for oncology and rare diseases, drive significant investment in specialized pediatric platforms. However, the market is witnessing a significant...0 Комментарии 0 Поделились 977 Просмотры 0 предпросмотр
-
Regulatory Affairs Services and Drug Development Support: Building a Comprehensive Life Sciences FrameworkThe management of drug development requires a sophisticated approach that combines effective regulatory affairs services with comprehensive drug development support. At the core of this approach are Regulatory Affairs Services , which provide the specialized expertise needed for successful regulatory submissions and compliance. The global life sciences BPO market, valued at USD 531.2...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Aβ-Protein Inhibitors Reshaping Alzheimer’s Disease Treatment and Drug DevelopmentThe Changing Alzheimer’s Disease Treatment Landscape Alzheimer’s disease treatment has increasingly shifted from managing symptoms toward disease modification, particularly with therapies designed to target amyloid-beta (Aβ), a protein associated with plaque accumulation in the brain. The development of amyloid beta inhibitors has provided clinical evidence that removing...0 Комментарии 0 Поделились 870 Просмотры 0 предпросмотр
-
Acute Agitation and Aggression Treatment Market Advances in Drug DevelopmentThe acute agitation and aggression treatment market is witnessing steady development as healthcare providers seek effective approaches for managing patients experiencing severe agitation, aggression, and related behavioral symptoms. The availability of pharmacological treatment options and growing attention toward timely behavioral management are supporting market expansion. The acute agitation...0 Комментарии 0 Поделились 441 Просмотры 0 предпросмотр
-
Advanced Formulation Research Creates Opportunities in Oral Peptide Drug DevelopmentPeptide therapeutics are attracting significant scientific interest because of their ability to interact with specific biological targets. However, their molecular characteristics create challenges for conventional oral drug delivery. Limited gastrointestinal stability and poor intestinal permeability can reduce the amount of an active peptide reaching systemic circulation. Addressing these...0 Комментарии 0 Поделились 69 Просмотры 0 предпросмотр
-
AI Drug Repurposing Market Growth, Excellent Development of Fintech Block Chain with Key Vendors Analysis By Fact.MRROCKVILLE, MARYLAND , Sept 18, 2026 – The AI drug repurposing market crossed a valuation of USD 1.3 billion in 2025. Demand is projected to increase from USD 1.5 billion in 2026 to USD 8.8 billion by 2036, recording a 19.4% compound annual growth rate (CAGR) over the forecast period, according to Fact.MR analysis. Absolute opportunity stands at USD 7.3 billion by 2036. Get...0 Комментарии 0 Поделились 685 Просмотры 0 предпросмотр
-
Albinism Drug Market: Advancements in Treatment and Drug DevelopmentThe albinism drug market is developing as healthcare systems place greater emphasis on improving diagnosis, treatment, and long-term care for individuals affected by albinism. Growing awareness of the condition and increasing attention to specialized healthcare are supporting opportunities for pharmaceutical and medical technology companies. The albinism drug market size was valued at US$...0 Комментарии 0 Поделились 421 Просмотры 0 предпросмотр
-
Alzheimer’s Therapeutics Market Forecast Highlights Innovation in Alzheimer’s Drug DevelopmentAccording to Future Market Insights (FMI), the global Alzheimer’s therapeutics market is projected to expand from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, registering a 9.2% CAGR during the forecast period. The market was valued at USD 3.9 billion in 2025, creating an incremental opportunity of approximately USD 6.5 billion through 2036. Donepezil is expected to account for...0 Комментарии 0 Поделились 523 Просмотры 0 предпросмотр
-
Analyzing the AI for Drug Development Market: Key Segments, Drivers, and Regional GrowthThe AI for drug development market is shaped by a complex interplay of technological innovation, pharmaceutical R&D needs, and regional investment priorities. The artificial intelligence for drug development and discovery market is on a powerful growth trajectory, projected to reach USD 35 billion by 2035. A detailed analysis of its segments and regional dynamics is essential for...0 Комментарии 0 Поделились 462 Просмотры 0 предпросмотр
-
Anticoagulant Medicine Market Advancements in Drug DevelopmentThe Anticoagulant Medicine Market continues to expand at a significant pace as the global burden of cardiovascular diseases, venous thromboembolism, and stroke-related conditions intensifies across aging populations. Anticoagulants, commonly known as blood thinners, play a critical role in preventing and treating thrombotic disorders by inhibiting clot formation and reducing the risk of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Комментарии 0 Поделились 804 Просмотры 0 предпросмотр
-
AI Clinical Trial Market Growing at 15% CAGR Through 2034According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in EuropeAlvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Autoimmune Polyglandular Syndrome Type 1 Market InsightsAutoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare inherited autoimmune disorder characterized by the dysfunction of multiple endocrine glands, resulting in chronic health complications that require lifelong medical management. Growing awareness of rare autoimmune diseases, advancements in diagnostic technologies, and increasing investments in targeted therapies are contributing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Biosimulation Market Expansion and the Rising Role of Predictive AnalyticsA drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is one of the central problems that the Biosimulation Market is increasingly addressing. Instead of relying entirely on physical experiments to understand how a drug may behave, researchers can use computational...0 Комментарии 0 Поделились 656 Просмотры 0 предпросмотр
-
From Preclinical Studies to Clinical Development: Building an Efficient Drug Development StrategyThe journey of a novel therapeutic molecule from an initial discovery concept to a commercially viable pharmaceutical product is one of the most complex, resource-intensive, and strictly regulated endeavors in modern science. Historically, the drug development lifecycle has been characterized by high attrition rates, escalating costs, and lengthy timelines. A critical factor separating...0 Комментарии 0 Поделились 789 Просмотры 0 предпросмотр
-
Global CRO Market Trends: Key Growth Drivers, Challenges, and OpportunitiesContract Research Organization Market to Grow at 9.7% CAGR, Reaching USD 179.4 Billion by 2033 Overview M2Square Consultancy estimates that the global Contract Research Organization (CRO) Market was valued at USD 88.3 billion in 2025 and is projected to reach USD 179.4 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.7% during the forecast period. Contract research...0 Комментарии 0 Поделились 744 Просмотры 0 предпросмотр
-
HDAC Inhibitor Market Segmentation Analysis by Indication and End UserThe global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Healthcare Contract Manufacturing Organization Market Industry Analysis, Revenue and Share ForecastThe healthcare industry is witnessing a significant transformation as pharmaceutical, biotechnology, and medical device companies increasingly rely on outsourcing partners to streamline production processes and accelerate product commercialization. Healthcare contract manufacturing organizations (CMOs) have become essential contributors to the global healthcare ecosystem, offering specialized...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Ionis (IONS) partner Roche shows sefaxersen cut IgA nephropathy proteinuria 43.1% in Phase 3Roche gave the first effect size from its IMAgINATION kidney trial at ASN Kidney Week, a clearer read for Ionis Pharmaceuticals Inc. (IONS) on a partnered drug that carries milestones and royalties. Sefaxersen cut proteinuria by 43.1% against placebo at 37 weeks in a Phase 3 trial in IgA nephropathy, according to data Ionis Pharmaceuticals Inc. (IONS) released on October 23. Roche Holding AG,...0 Комментарии 0 Поделились 809 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek